Supplementary material Adipogenic differentiation
For adipogenic differentiation, cells were grown to 90% confluency and then treated with adipogenic differentiation medium containing DMEM high glucose (Sigma, USA), 10% FBS (Gibco), 2 mМ L-glutamine (Biomedicals), 5 mМ НЕРЕS (Biomedicals), 1 µM dexamethasone (Sigma, USA), 0.5 mM 3-isobutyl-1-methylxanthine (Sigma, USA), 0.06 mM indomethacin (Sigma, USA), 5 µg/ml insulin (Biochrom), 100 U/ml penicillin, and 50 µg/ml streptomycin (Sigma, USA).
The medium was replaced twice weekly. After 21 days of incubation in the adipogenic induction medium, this medium was aspirated and the cells were washed with PBS. Cells were fixed with 4% paraformaldehyde (PFA) and washed with sterile water. Next, the cells were incubated with 60% isopropanol at RT for 5 min and dried. The cultures were incubated with Oil Red O (Sigma, USA) solution (0.5% vol/vol in isopropanol) for 20 min at RT. After staining, the cells were washed with distilled water before microscopy. In addition, PDMCs were pelleted, and total RNA was collected after 21 days for adipogenic gene expression analysis by qRT-PCR.
qRT-PCR reactions were carried out as described below with the specific primers for PPARG2 (Table S1 ), normalized to endogenous ACTB and compared to basal expression levels in non-differentiated cells.
Differentiation control PDMCs were cultured in complete culture medium for 21 days and estimated for adipogenic differentiation by staining with Oil Red O (Sigma, USA) and qRT-PCR as described above.
Osteogenic differentiation
For osteogenic differentiation, cells were treated with osteogenic differentiation medium containing DMEM high glucose (HyClone), 10% FBS (Gibco), 2 mМ L-glutamine (Biomedicals), 5 mМ НЕРЕS (Biomedicals), 0.1 mM ascorbic acid 2-phosphate (Sigma, USA), 0.1 µM dexamethasone (Sigma, USA), 10 mM β-glycerophosphate (Sigma, USA), 100 U/ml penicillin and 50 µg/ml streptomycin (Sigma, USA). The cells were placed on 6-well plates. When the cells were of 80-90% confluence in a monolayer, the culture medium was changed to osteogenic differentiation medium, and the cells were incubated for 21 days. The differentiation medium was changed twice a week. Alizarin Red S staining was performed at day 21 to assess extracellular calcium deposition. For Alizarin Red S staining, the cells were washed with PBS and fixed with ice-cold 70% ethanol for 5 min at RT. Next, the cells were rinsed three to four times with distilled water and stained with 0.5% Alizarin Red S (pH 4.2, Sigma, USA) for 10 min at RT. The cells were rinsed with distilled water to remove excess dye before observing under the microscope for imaging. PDMCs were pelleted, and RNA was collected after 21 days for osteogenic gene expression analysis byqRT-PCR. qRT-PCR reactions were carried out as described below using specific primers for osteopontin (SPP1) (Table   S1 ), normalized to endogenous ACTB and compared to basal expression levels in non-differentiated cells. As differentiation control, PDMCs were cultured in complete culture medium for 21 days and estimated for osteogenic differentiation by staining with Alizarin Red S (Sigma, USA) and qRT-PCR as described above.
RNA extraction and RT-PCR
Total RNA was isolated using TRI Reagent (Sigma, USA) and stored at -80 °C. Trace amounts of genomic DNA were removed by RNAse-free DNAse I treatment (Thermo Scientific, USA). Then, cDNA was synthesized from 1 µg of total RNA with oligo(dT) 18 primers and RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific, USA) according to the manufacturer's instructions. Two percent of the first-strand cDNA was amplified by sequence-specific primers (Table   S1) POU5F1 [7] AAGCGATCAAGCAGCGACTAT GGAAAGGGACCGAGGAGTACA 58 132
PPARG2 [8] TGTCAGTACTGTCGGTTTC AATGGTGATTTGTCTGTTG 56 257
SPP1[9]
CTAGGCATCACCTGTGCCATACC CAGTGACCAGTTCATCAGATTCATC 57 373
ACTB[1]
GGACTTCGAGCAAGAGAT AGCACTGTGTTGGCGTAC 57 234 Table S2 . Antibodies used for cell characterization by flow cytometry. 
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